Zerinolnazal
care

Description
Medical device containing resveratrol from Polygonum cuspidatum and carboxymethyl beta-glucan in a buffered saline solution. The product, administered topically through the nasal route, may be useful for people with an increased predisposition to inflammation and/or infections of the nasal cavities and upper respiratory tract.
Useful medical device for removing mucus residues and facilitating breathing. Adjuvant in the treatment of nasal inflammation. Suitable for adults and children aged 3 years and over.

How to use
1-2 sprays per nostril 3 or 4 times a day.
Before using the product for the first time, screw the bottle cap clockwise until it stops, so that the powder inside the cap falls into the liquid. Shake vigorously and replace the cap with the sprayer included in the package, screwing it tightly.
Remove the spray cap and spray into the nostrils. Shake before each use. After use, clean the sprayer and replace the protective cap. For younger children, it is recommended that the spray be carried out by an adult. The presence of resveratrol (extract from the Polygonum cuspidatum plant) may cause the product to have a slightly amber color, but this does not affect its quality.

components
Purified water to taste, carboxymethyl betaglucan 0.0066%, Polygonum cuspidatum rhizome titrated to 98% in resveratrol 0.0507%, dipotassium phosphate, mannitol, propylene glycol, sodium chloride 0.2298%, potassium phosphate, sodium nipago.

warnings
Do not use if you have a known hypersensitivity to any of the product components. If you experience adverse reactions, discontinue use and consult a physician. Close the device tightly after use. Do not use after the stated expiration date. The reconstituted product is stable for 28 days. Use the reconstituted product within 28 days. Keep out of reach of children.
The use of the bottle is strictly personal. Pregnant or breastfeeding women are advised to consult a doctor. Do not use the product if the packaging is opened or damaged. It is recommended not to take medications or other devices before or immediately after its use, to avoid excretion. Any serious incident involving the medical device must be reported to the manufacturer and the competent authority of the Member State where the device is located.

Format
30 ml bottle with dispenser cap and nasal spray.

Code LVIR P